Synthesis and Antitumor Mechanism of a Fluorescent Cyclic Peptide Selectively Targeting Integrin αvβ3 on Hepatocellular Carcinoma
Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 10877-10891
DOI: 10.1021/acs.jmedchem.6c00071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.04.2026. Verfasst von Zhiqin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: Peptides, Cyclic, Liver Neoplasms, Integrin alphaVbeta3, Antineoplastic Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Fudan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, Shanghai 201203, China.
ORCID-Profile: Zhiqin Zhang, Ping Yang
Förderung
- Fudan University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Li, L., Liu, X., Wei, S., Yang, H., Yang, P., & Mu, Q. (2026). Synthesis and Antitumor Mechanism of a Fluorescent Cyclic Peptide Selectively Targeting Integrin αvβ3 on Hepatocellular Carcinoma. Journal of Medicinal Chemistry, 69(9), 10877-10891. https://doi.org/10.1021/acs.jmedchem.6c00071
Vancouver
Zhang Z, Li L, Liu X, Wei S, Yang H, Yang P, et al. Synthesis and Antitumor Mechanism of a Fluorescent Cyclic Peptide Selectively Targeting Integrin αvβ3 on Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 2026;69(9):10877-10891. doi:10.1021/acs.jmedchem.6c00071
BibTeX
@article{Zhang2026,
author = {Zhang, Zhiqin and Li, Lingyun and Liu, Xiao and Wei, Siqi and Yang, Huirun and Yang, Ping and Mu, Qing},
title = {Synthesis and Antitumor Mechanism of a Fluorescent Cyclic Peptide Selectively Targeting Integrin αvβ3 on Hepatocellular Carcinoma},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {9},
pages = {10877--10891},
doi = {10.1021/acs.jmedchem.6c00071}
}
EUVIMED